Showing 61 - 80 results of 269 for search '"vaccine"', query time: 0.10s Refine Results
  1. 61
  2. 62

    Toward trustworthy COVID-19 interventions: Building vaccine trust through community-university partnerships. by Laura A Bray, Lori L Jervis, Amanda E Janitz, Laura Ross, Gloria Tallbull, Timothy M VanWagoner, CATCH-UP Vaccines Team

    Published 2024-01-01
    “…Prior research identifies trust as critical to increase vaccine acceptance and uptake. However, few intervention studies have sought to develop or test strategies for bolstering vaccine-related trust. …”
    Get full text
    Article
  3. 63
  4. 64
  5. 65
  6. 66
  7. 67
  8. 68

    Assessing the Health and Economic Outcomes of a 9-Valent HPV Vaccination Program in the United Kingdom by Kwame Owusu-Edusei, Cody Palmer, Olga Ovcinnikova, Giampiero Favato, Vincent Daniels

    Published 2022-06-01
    “…**Background:** The United Kingdom (UK) switched from using the 4-valent human papillomavirus (HPV) vaccine (Gardasil®) to the 9-valent vaccine (Gardasil 9®) in 2021. …”
    Get full text
    Article
  9. 69
  10. 70
  11. 71

    COVID-19 vaccination: Knowledge and perception of beneficiaries at a tertiary care center in Haryana, India by Garima Sangwan, Nitika Sharma, Rajesh Garg

    Published 2025-02-01
    “…Despite the availability of vaccines, there were reports of vaccine hesitancy among people, including healthcare workers. …”
    Get full text
    Article
  12. 72
  13. 73
  14. 74
  15. 75
  16. 76

    Saccharomyces Boulardii and Saccharomyces Cerevisiae Improve Immunity in Broilers Vaccinated Against Pasteurella Multocida and Salmonella Gallinarum by C Von Mühlen, NL Conrad, AP Roll, RC Dias, FPL Leite, CD Corcini, AS Varela Junior, VFB Roll

    Published 2025-02-01
    “…A total of 105 male Cobb 500 broilers were divided into four groups: T1 (vaccinated, no supplement, n = 30), T2 (vaccinated, S. boulardii supplement, n = 30), T3 (vaccinated, S. cerevisiae supplement, n = 30), and T4 (non-vaccinated, no supplement, n = 15). …”
    Get full text
    Article
  17. 77
  18. 78

    PROTACs: Mechanism and Bioavailability enhancement strategies by nanotechnology, RNA viral infections (vaccine strategy) and Prodrug development by Sanaul Mustafa, Md Sabir Hussain Siddiquee

    Published 2025-01-01
    “…Moreover, arguably the most interesting virtue of PROTACs is its applicability for RNA viral infections (new vaccine design) based on the degradation of viral proteins. …”
    Get full text
    Article
  19. 79
  20. 80